首页 | 本学科首页   官方微博 | 高级检索  
     

靶向调控AQP4对非小细胞肺癌细胞化疗敏感性的调控作用
引用本文:郭守俊,谢传华,黄萍,邱伊连,王硕,班振英,张威. 靶向调控AQP4对非小细胞肺癌细胞化疗敏感性的调控作用[J]. 天津医药, 2019, 47(5): 468-472. DOI: 10.11958/20182189
作者姓名:郭守俊  谢传华  黄萍  邱伊连  王硕  班振英  张威
作者单位:基金项目:河南省高等学校重点科研项目(17A310027)作者单位:1赣州市肿瘤医院内一科(邮编341000);2郑州大学第三附属医院病理科作者简介:郭守俊(1971),男,学士,主任医师,主要从事胸部肿瘤的临床诊断、治疗研究△通讯作者 E-mail:jxgzguosj@126.com
基金项目:河南省高等学校重点科研项目
摘    要:
摘要:目的 探讨靶向沉默水通道蛋白4(AQP4)基因对非小细胞肺癌细胞化疗敏感性影响,并研究其分子作用机制。方法 实时荧光定量 PCR(qRT-PCR)和 Western blot 分别检测非小细胞肺癌 A549 细胞以及顺铂耐药菌株A549/DDP中AQP4 mRNA和蛋白的表达。设计靶向AQP4的siRNA-1和siRNA-2,采用siRNA抑制A549/DDP细胞中AQP4的表达,筛选出最优siRNA,将其转染A549/DDP细胞,设立siRNA-NC组和空白对照组。CCK-8法检测细胞增殖能力并计算各组细胞的半数抑制浓度(IC50);流式细胞术检测细胞凋亡。Western blot检测P53和Bcl-2蛋白的表达。结果 AQP4 mRNA和蛋白在A549/DDP细胞中的表达水平显著高于A549细胞,AQP4表达沉默后A549/DDP细胞增殖抑制,细胞凋亡增加,对顺铂的敏感性增加,凋亡相关蛋白P53表达增加,而Bcl-2蛋白表达降低。结论 通过靶向调控AQP4的表达可以增加非小细胞肺癌细胞对化疗药物的敏感性。

关 键 词:非小细胞肺癌  靶向调控  耐药性  AQP4  RNA干扰  
收稿时间:2019-01-02
修稿时间:2019-04-01

The effect of silencing AQP4 expression on the chemotherapy sensitivity ofnon-small cell lung cancer
GUO Shou-jun,XIE Chuan-hua,HUANG Ping,QIU Yi-lian,WANG Shuo,BAN Zhen-ying,ZHANG Wei. The effect of silencing AQP4 expression on the chemotherapy sensitivity ofnon-small cell lung cancer[J]. Tianjin Medical Journal, 2019, 47(5): 468-472. DOI: 10.11958/20182189
Authors:GUO Shou-jun  XIE Chuan-hua  HUANG Ping  QIU Yi-lian  WANG Shuo  BAN Zhen-ying  ZHANG Wei
Affiliation:1 Department of Medical Oncology, Ganzhou Cancer Hospital, Ganzhou 341000, China;2 Department of Pathology, the Third Affiliated Hospital of Zhengzhou University△Corresponding Author E-mail: jxgzguosj@126.com
Abstract:
ponding Author E-mail: jxgzguosjAbstract: Objective To investigate the effect of targeting silenced aquaporin 4 (AQP4) gene on the chemotherapysensitivity of non-small cell lung cancer (NSDCLC) and its mechanism. Methods The qRT-PCR method and Western boltassay were used to detect the expression of AQP4 in A549 and A549/DDP cell lines (human cisplatin-resistant NSDCLC cellline). The siRNA-1 and siRNA-2 targeting AQP4 were designed. AQP4 expression was blocked by the siRNA in A549/DDPcells. The optimal siRNA was screened and transfected into A549/DDP cells. siRNA-NC and blank cells were set up ascontrols. The proliferation and half inhibitory concentration (IC50) of A549/DDP cells were detected by CCK8 method. Theapoptosis of U251 cells was detected by AnnexinV- FITC/PI double marker flow cytometry. The expressions of P53 and Bcl-2 were detected by Western blot assay. Results The expressions of AQP4 mRNA and protein were significantly increasedin A549 /DDP cells compared with A549 cells. After silencing AQP4 expression, the proliferation was inhibited and theapoptosis rate was significantly increased in A549 / DDP cells. Silencing AQP4 expression significantly increased thesensitivity to cisplatin in lung cancer cells. AQP4 knockdown could also up-regulate the expression of P53, and downregulate the expression of Bcl-2. Conclusion The selective targeting of the AQP4 expression can increase the sensitivity ofNSDCLC cells to chemotherapeutic drugs.
Keywords:NSCLC  target regulating  durg-resistance  AQP4  RNA interference  
点击此处可从《天津医药》浏览原始摘要信息
点击此处可从《天津医药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号